Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions
Autoimmune Diseases, Cardiovascular Disorders, Diabetes Complications
About this trial
This is an interventional treatment trial for Autoimmune Diseases focused on measuring stem cell therapy, umbilical cord stem cells, amniotic stem cells, stem cells, MSC, Mesenchymal Stem Cell, Medicinal Signaling Cell, Erectile Dysfunction, Heart Diseases, Mental Disorders, Neurocognitive Disorders, Neurodegenerative Diseases, Central Nervous System Diseases, Tauopathies, Brain Diseases, Dementia, Disease, Cardiomyopathies, Urologic Diseases, Peripheral Nervous System Diseases, Nervous System Diseases, Alzheimer Disease, Musculoskeletal Diseases, Cardiovascular Diseases, Immune System Diseases, Neuromuscular Diseases, Covid-19
Eligibility Criteria
Inclusion Criteria:
- Age 18 and older
- Ability to provide informed consent
- Availability for follow up visits
Exclusion Criteria:
- Active or recent malignancy (within last 2 years)
- Pregnancy or breast-feeding
- Inability to provide informed consent
Sites / Locations
- Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator SitesRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Arm 6
Arm 7
Arm 8
Arm 9
Arm 10
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Experimental
Arm 1: Autoimmune Diseases
Arm 2: Cardiovascular Disorders
Arm 3: Diabetes Complications
Arm 4: Integumentary Disease
Arm 5: Musculoskeletal Disorders
Arm 6: Neurodegenerative Disorders
Arm 7: Pulmonary Disorders
Arm 8: Sexual Dysfunction
Arm 9: Urologic Disorders
Arm 10: Viral Illnesses
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for autoimmune conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for cardiovascular disorders and conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for diabetes complications. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for integumentary diseases and conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for orthopedic and musculoskeletal conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for neurologic and neurodegenerative disorders. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for pulmonary disorders. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for sexual dysfunction conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for urologic conditions. Outcomes will be compared to results in peer-reviewed literature for several conditions.
Purpose is to evaluate an amniotic and umbilical cord stem cell rich tissue substance for viral illnesses. Outcomes will be compared to results in peer-reviewed literature for several conditions.